Mint Tower Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Mint Tower Capital Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,035	Closed	-$30K	–	356
2025 Q4	$30K	Buy	+1,035	New	+$19.7K	﹤0.01%	227

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mint Tower Capital Management's MRSN Position: Q1 2026 in Review

Mint Tower Capital Management sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 1,035 shares — an estimated $30K sold.

Mint Tower Capital Management first reported a position in MRSN in Q4 2025 and held it in 1 quarter. The position peaked at $30K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Mint Tower Capital Management reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Mint Tower Capital Management sold 1,035 Mersana Therapeutics shares in Q1 2026, an estimated $30K.
Mint Tower Capital Management first reported a position in Mersana Therapeutics in Q4 2025 and held it in 1 quarter.
Mint Tower Capital Management's Mersana Therapeutics position peaked at $30K in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Mint Tower Capital Management's 13F filing for Q1 2026, filed 4 May 2026.